W 787 (Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg)
Pill imprint W 787 has been identified as Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 50 mg / 200 mg / 200 mg is not subject to the Controlled Substances Act.
See also related documents.
- 50 mg / 200 mg / 200 mg
- Elliptical / Oval
- Prescription only
More about carbidopa/entacapone/levodopa
- Carbidopa, entacapone, and levodopa
- Carbidopa, entacapone, and levodopa (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.